Similarly, the in vivo animal experiments on nude mice showed that the targeted drugs (PGS-LHRH and PTX-LHRH) prevent the locoregional recurrence of TNBC, following tumor resection and the implantation of PLGA-PEG microcapsules that elute the targeted drugs. Here, GNRH1 is linked to neoplasm.